Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Peaches who wrote (453)	12/21/1998 6:15:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 642

Lilly Boosts Dividend 15% to 23 Cents a Shr as Drug Sales Rise Bloomberg News December 21, 1998, 12:40 p.m. PT Lilly Boosts Dividend 15% to 23 Cents a Shr as Drug Sales Rise Indianapolis, Dec. 21 (Bloomberg) -- Eli Lilly & Co., the maker of the world's best-selling antidepressant Prozac, said it will boost its quarterly dividend 15 percent to 23 cents a share from 20 cents as sales of Prozac and its other drugs increase. Lilly is the third large U.S. drugmaker this month to announce a boost in the 1999 dividend. Pfizer Inc., the maker of the impotence pill Viagra, and Bristol-Myers Squibb Co., which makes the diabetes drug Glucophage and Clairol hair-care products, also said they will raise their dividends next year. Drugmakers' profits are rising partly as a result of new rules that let them direct more ads at consumers. Lilly has been advertising for its bone-protecting drug Evista as well as for Prozac. Indianapolis-based Lilly said this is the largest increase in its dividend since 1991. The dividend is payable March 10 to shareholders of record as of Feb. 12. Lilly fell 2 11/16 to 84 5/8 in late trading. --Kerry Dooley in the Princeton newsroom (609) 279-4016/gfh